Worg Pharmaceuticals

company

About

Worg Pharmaceuticals is a clinical stage biopharmaceutical company developing new treatments for allergy and other diseases.

  • 1 - 10

Details

Last Funding Type
Series B
Last Funding Money Raised
¥400M
Industries
Biotechnology
Founded date
Jan 1, 2018
Number Of Employee
1 - 10
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥400M
Worg Pharmaceuticals has raised a total of ¥400M in funding over 2 rounds. Their latest funding was raised on Sep 14, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 14, 2022 Series B ¥400M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Worg Pharmaceuticals is funded by 1 investors. Longqian Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Longqian Capital Series B